Furthermore, in these five MSI-H cases, no correlations were found between the MSI-H and clinicopathological factors including age, FIGO stage, initial treatment, status of residual tumor, status of ARID1A expression, and the status of endometriosis (Table 1). This evidence concerns the gene ARID1A and neoplasm.